| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Section of Nuclear Endocrinology, Division of Nuclear Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan
Correspondence: For reprints contact: B. Shapiro, MB, ChB, PhD, Div. of Nuclear Medicine, University of Michigan Medical Center, 1405 East Ann St., Ann Arbor, MI 48109.
ABSTRACT
The efficacy of the newly developed pheochromocytoma-seeking radiopharmaceutical, [131I]MIBG, was examined in the first 400 patients (441 studies) investigated for suspected pheochromocytoma at our institution. The results of [131I]MIBG scintigraphy were classified as true positive, false positive, true negative, and false negative. Using this classification the sensitivity was found to be 78.4% in primary, sporadic pheochromocytoma, 92.4% in malignant pheochromocytoma, and 94.3% in familial pheochromocytoma giving an overall sensitivity of 87.4%. The specificity was 98.9% in primary, sporadic pheochromocytoma, 100% in malignant pheochromocytoma, and 100% in familial pheochromocytoma. The overall specificity was 98.9%. Iodine-131 MIBG scintigraphy was thus found to be a safe, noninvasive, and efficacious technique for the location of pheochromocytomas, especially for those arising from nonadrenal sites, recurring postoperatively, and exhibiting malignant metastatic disease. We find that, where available, [131I]MIBG scintigraphy is the study of choice to initiate the location of suspected pheochromocytoma.
This article has been cited by other articles:
|
|
 |
|
  G. W. L. Boland, M. A. Blake, P. F. Hahn, and W. W. Mayo-Smith Incidental Adrenal Lesions: Principles, Techniques, and Algorithms for Imaging Characterization Radiology, December 1, 2008; 249(3): 756 - 775. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. H. Hinkle, J. V. Dura, R. S. Morosco, and M. C. Nahata Extended stability of iobenguane under simulated clinical conditions Am. J. Health Syst. Pharm., January 15, 2008; 65(2): 142 - 144. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. J. G. Oyen, L. Bodei, F. Giammarile, H. R. Maecke, J. Tennvall, M. Luster, and B. Brans Targeted therapy in nuclear medicine current status and future prospects Ann. Onc., November 1, 2007; 18(11): 1782 - 1792. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M F Stewart, J Croft, P Reed, and J P New Acute intermittent porphyria and phaeochromocytoma: shared features J. Clin. Pathol., August 1, 2007; 60(8): 935 - 936. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Asari, C. Scheuba, K. Kaczirek, and B. Niederle Estimated Risk of Pheochromocytoma Recurrence After Adrenal-Sparing Surgery in Patients With Multiple Endocrine Neoplasia Type 2A Arch Surg, December 1, 2006; 141(12): 1199 - 1205. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D Cecchin, F Lumachi, M C Marzola, G Opocher, C Scaroni, P Zucchetta, F Mantero, and F Bui A meta-iodobenzylguanidine scintigraphic scoring system increases accuracy in the diagnostic management of pheochromocytoma. Endocr. Relat. Cancer, June 1, 2006; 13(2): 525 - 533. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Kaltsas, G. M. Besser, and A. B. Grossman The Diagnosis and Medical Management of Advanced Neuroendocrine Tumors Endocr. Rev., June 1, 2004; 25(3): 458 - 511. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Sawka, A. Gafni, L. Thabane, and W. F. Young Jr. The Economic Implications of Three Biochemical Screening Algorithms for Pheochromocytoma J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2859 - 2866. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Goldstein, G. Eisenhofer, J. A. Flynn, G. Wand, and K. Pacak Diagnosis and Localization of Pheochromocytoma Hypertension, May 1, 2004; 43(5): 907 - 910. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Mansmann, J. Lau, E. Balk, M. Rothberg, Y. Miyachi, and S. R. Bornstein The Clinically Inapparent Adrenal Mass: Update in Diagnosis and Management Endocr. Rev., April 1, 2004; 25(2): 309 - 340. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Rha, J. Y. Byun, S. E. Jung, H. J. Chun, H. G. Lee, and J. M. Lee Neurogenic Tumors in the Abdomen: Tumor Types and Imaging Characteristics RadioGraphics, January 1, 2003; 23(1): 29 - 43. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y Inoue, M Akahane, T Kitazawa, H Ijichi, S Obi, K Yoshikawa, K Ohtomo, and M Omata False positive uptake of metaiodobenzylguanidine in hepatocellular carcinoma Br. J. Radiol., June 1, 2002; 75(894): 548 - 551. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Yanik, J. E. Levine, K. K. Matthay, J. C. Sisson, B. L. Shulkin, B. Shapiro, D. Hubers, S. Spalding, T. Braun, J. L.M. Ferrara, et al. Pilot Study of Iodine-131-Metaiodobenzylguanidine in Combination With Myeloablative Chemotherapy and Autologous Stem-Cell Support for the Treatment of Neuroblastoma J. Clin. Oncol., April 15, 2002; 20(8): 2142 - 2149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A G Rockall and A Sahdev Functioning adrenal pathology Imaging, April 1, 2002; 14(2): 122 - 136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. W. Mayo-Smith, G. W. Boland, R. B. Noto, and M. J. Lee State-of-the-Art Adrenal Imaging RadioGraphics, July 1, 2001; 21(4): 995 - 1012. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Chao, M. E. Mullins, and P. J. Slanetz Posterior Mediastinal Pheochromocytoma Am. J. Roentgenol., June 1, 2001; 176(6): 1408 - 1408. [Full Text] [PDF]
|
|
|
|
|
|
E. van der Harst, W. W. de Herder, H. A. Bruining, H. J. Bonjer, R. R. de Krijger, S. W. J. Lamberts, A. H. van de Meiracker, F. Boomsma, T. Stijnen, E. P. Krenning, et al. [123I]Metaiodobenzylguanidine and [111In]Octreotide Uptake in Benign and Malignant Pheochromocytomas J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 685 - 693. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Cortes-Blanco, R. Martinez-Lazaro, and C. Martinez-Duncker Unusual diffuse [131I]MIBG accumulation in a kidney with renal artery stenosis Nephrol. Dial. Transplant., November 1, 2000; 15(11): 1885 - 1886. [Full Text] [PDF]
|
|
|
|
|
|
M. L. Grebenc, M. L. Rosado de Christenson, A. P. Burke, C. E. Green, and J. R. Galvin Primary Cardiac and Pericardial Neoplasms: Radiologic-Pathologic Correlation RadioGraphics, July 1, 2000; 20(4): 1073 - 1103. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Nagesser, J. Kievit, J. Hermans, H. M. J. Krans, and C. J.H. van de Velde The Surgical Approach to the Adrenal Gland: a Comparison of the Retroperitoneal and the Transabdominal Routes in 326 Operations on 284 Patients Jpn. J. Clin. Oncol., February 1, 2000; 30(2): 68 - 74. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Rainis, S. Ben-Haim, and G. Dickstein False Positive Metaiodobenzylguanidine Scan in a Patient with a Huge Adrenocortical Carcinoma J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 5 - 7. [Abstract] [Full Text]
|
|
|
|
|
|
B. L. Shulkin, N. W. Thompson, B. Shapiro, I. R. Francis, and J. C. Sisson Pheochromocytomas: Imaging with 2-[Fluorine-18]fluoro-2-deoxy-D-glucose PET Radiology, July 1, 1999; 212(1): 35 - 41. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. C. Lin, B. A. Palafox, H. A. Jackson, A. J. Cohen, and A. B. Gazzaniga Cardiac pheochromocytoma: resection after diagnosis by 111-indium octreotide scan Ann. Thorac. Surg., February 1, 1999; 67(2): 555 - 558. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sandur, A. Dasgupta, J. L. Shapiro, A. C. Arroliga, and A. C. Mehta Thoracic Involvement With Pheochromocytoma: A Review Chest, February 1, 1999; 115(2): 511 - 521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Barzon, C. Scaroni, N. Sonino, F. Fallo, M. Gregianin, C. Macri’, and M. Boscaro Incidentally Discovered Adrenal Tumors: Endocrine and Scintigraphic Correlates J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 55 - 62. [Abstract] [Full Text]
|
|
|
|
 |
|
 H. R. Keiser Surreptitious Self-administration of Epinephrine Resulting in 'Pheochromocytoma' JAMA, September 18, 1991; 266(11): 1553 - 1555. [Abstract] [PDF]
|
|
|
|
 |
|
 M. W. Hanson, J. M. Feldman, C. A. Beam, G. S. Leight, and R. E. Coleman Iodine 131--Labeled Metaiodobenzylguanidine Scintigraphy and Biochemical Analyses in Suspected Pheochromocytoma Arch Intern Med, July 1, 1991; 151(7): 1397 - 1402. [Abstract] [PDF]
|
|
|
|
|
|
J. H. Thrall Nuclear Medicine JAMA, June 19, 1991; 265(23): 3137 - 3139. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |
